Open access · CC-BY
via OpenAlex
Hyperinsulinemia and Its Pivotal Role in Aging, Obesity, Type 2 Diabetes, Cardiovascular Disease and Cancer
International Journal of Molecular Sciences · 2021 · ▲ 309 citations
Abstract
For many years, the dogma has been that insulin resistance precedes the development of hyperinsulinemia. However, recent data suggest a reverse order and place hyperinsulinemia mechanistically upstream of insulin resistance. Genetic background, consumption of the "modern" Western diet and over-nutrition may increase insulin secretion, decrease insulin pulses and/or reduce hepatic insulin clearance, thereby causing hyperinsulinemia. Hyperinsulinemia disturbs the balance of the insulin-GH-IGF axis and shifts the insulin : GH ratio towards insulin and away from GH. This insulin-GH shift promotes energy storage and lipid synthesis and hinders lipid breakdown, resulting in obesity due to higher fat accumulation and lower energy expenditure. Hyperinsulinemia is an important etiological factor in the development of metabolic syndrome, type 2 diabetes, cardiovascular disease, cancer and premature mortality. It has been further hypothesized that nutritionally driven insulin exposure controls the rate of mammalian aging. Interventions that normalize/reduce plasma insulin concentrations might play a key role in the prevention and treatment of age-related decline, obesity, type 2 diabetes, cardiovascular disease and cancer. Caloric restriction(definition), increasing hepatic insulin clearance and maximizing insulin sensitivity are at present the three main strategies available for managing hyperinsulinemia. This may slow down age-related physiological decline and prevent age-related diseases. Drugs that reduce insulin (hyper) secretion, normalize pulsatile insulin secretion and/or increase hepatic insulin clearance may also have the potential to prevent or delay the progression of hyperinsulinemia-mediated diseases. Future research should focus on new strategies to minimize hyperinsulinemia at an early stage, aiming at successfully preventing and treating hyperinsulinemia-mediated diseases.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3390/ijms22157797
- Canonical
- link ↗
- Fetched
- 2026-09-09 MST
Cite this
APA
Janssen, J.A.M.J.L. (2021). Hyperinsulinemia and Its Pivotal Role in Aging, Obesity, Type 2 Diabetes, Cardiovascular Disease and Cancer. <em>International Journal of Molecular Sciences</em>. https://doi.org/10.3390/ijms22157797
Vancouver
Janssen JAMJL. Hyperinsulinemia and Its Pivotal Role in Aging, Obesity, Type 2 Diabetes, Cardiovascular Disease and Cancer. International Journal of Molecular Sciences. 2021. doi:10.3390/ijms22157797.
BibTeX
@article{j2021Hyperi,
title = {Hyperinsulinemia and Its Pivotal Role in Aging, Obesity, Type 2 Diabetes, Cardiovascular Disease and Cancer},
author = {J. A. M. J. L. Janssen},
journal = {International Journal of Molecular Sciences},
year = {2021},
doi = {10.3390/ijms22157797},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Current Alzheimer Research 2007
Citation only
Insulin Resistance, Glycemic Control and Adiposity: Key Determinants of Healthy Lifespan
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) 2025
Open access · CC-BY
Arterial stiffness, cardiovascular disease and the risk of type 2 diabetes mellitus
Työväentutkimus Vuosikirja 2008
Open access · OA
LIVER FAT IN THE METABOLIC SYNDROME AND TYPE 2 DIABETES
International Journal of Molecular Sciences 2021
Open access · CC-BY
The Role of the Gut Microbiome in Diabetes and Obesity-Related Kidney Disease
Frontiers in endocrinology 2026
Open access · OA
Thyroid dysfunction in aging and cardiovascular-kidney-metabolic syndrome: metabolic regulation and clinical implications.
Diabetes Obesity and Metabolism 2024
Open access · CC-BY